Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 451 - 475 of 628 in total
CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.
Investigational
Netivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.
Investigational
Emicerfont has been used in trials studying the diagnostic and treatment of Social Anxiety Disorder and Irritable Bowel Syndrome (IBS).
Investigational
2'-fluoro-5-ethylarabinosyluracil (FAU) has been used in trials studying the treatment of Small Intestine Lymphoma, Stage IV Mantle Cell Lymphoma, Waldenström Macroglobulinemia, Splenic Marginal Zone Lymphoma, and Recurrent Mantle Cell Lymphoma, among others.
Investigational
CT-2584 has been used in trials studying the treatment of Prostate Cancer.
Investigational
Doxifluridine has been investigated for the treatment of Stomach Cancer.
Investigational
An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]
Experimental
SP-8203 has been used in trials studying the treatment of Ischemic Stroke.
Investigational
5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.
Experimental
Experimental
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
Curcuma xanthorrhiza oil is extracted from Curcuma xanthorrhiza Roxb., a member of the ginger family (Zingiberaceae) that is widely distributed in the region of Southeastern Asia . Curcuma xanthorrhiza is also known as Javanese Turmeric or Temoe Lawak . For centuries, Curcuma xanthorrhiza oil has been used as a traditional...
Nutraceutical
Displaying drugs 451 - 475 of 628 in total